Clinical Diagnosis and Prognosis of Steatotic Liver Disease
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 71
Special Issue Editor
Interests: steatotic liver disease; hepatocellular carcinoma; hepatotoxicity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Steatotic liver disease (SLD) has emerged as the novel nomenclature for NAFLD, defined by “A multi-society Delphi consensus statement on new fatty liver disease nomenclature". It includes sub-classifications, such as metabolic-associated steatotic liver disease (MASLD); alcohol-related SLD (SLD-ALD); specific-etiology SLD (DILI; monogenetic diseases, miscellaneous); and cryptogenic SLD: unknown causes.
SLD, considered the most prevalent liver disease today, has enhanced our knowledge of all aspects of the disease, including its epidemiology, clinical profile, diagnosis, and treatment. Advances have also been achieved in precision medicine, which will soon be integrated into SLD clinical practice. However, unmet practical needs are still present in most clinical aspects of this liver disease.
In this Special Issue, clinical diagnostic and prognostic advances in SLD through original research articles, reviews, short communications, and interesting images are welcome.
We look forward to your collaboration.
Dr. Helma Pinchemel Cotrim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- steatotic liver disease—SLD
- steatohepatitis
- steatosis
- diagnosis
- prognosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
